Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors

Bioorganic & Medicinal Chemistry Letters
2019.0

Abstract

Herein we report a study of novel arylchromene derivatives as analogs of naturally occurring flavonoids with prominent α-glucosidase inhibitory properties. Novel inhibitors were identified via simple stepwise in silico screening, efficient synthesis, and biological evaluation. It is shown that 2-aryl-4H-chromene core retains pharmacophore properties while being readily available synthetically. A lead compound identified through screening inhibits yeast α-glucosidase with IC<sub>50</sub> of 62.26 µM and prevents postprandial hyperglycemia in rats at 2.2 mg/kg dose.

Knowledge Graph

Similar Paper

Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2019.0
Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
α-Glucosidase inhibitory antihyperglycemic activity of substituted chromenone derivatives
Bioorganic &amp; Medicinal Chemistry 2010.0
Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors
Bioorganic &amp; Medicinal Chemistry 2017.0
2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors
Bioorganic &amp; Medicinal Chemistry 2015.0
Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
α-Glucosidase inhibition activity and in silico study of 2-(benzo[d][1,3]dioxol-5-yl)-4H-chromen-4-one, a synthetic derivative of flavone
Bioorganic &amp; Medicinal Chemistry 2019.0
Synthesis and α-glucosidase inhibitory activity evaluation of N-substituted aminomethyl-β-d-glucopyranosides
Bioorganic &amp; Medicinal Chemistry 2013.0
Novel quinoline derivatives as potent in vitro α-glucosidase inhibitors: in silico studies and SAR predictions
MedChemComm 2015.0
Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes
Bioorganic &amp; Medicinal Chemistry Letters 2021.0